Nosocomial Staphylococcus aureus bacteremia among nasal carriers of methicillin-resistant and methicillin-susceptible strains

American Journal of Medicine

Volumn 100, Issue 5, 1996, Pages 509-516

  Pujol, Miquel ^a,b   Peña, Carmen ^a   Pallares, Roman ^a   Ariza, Javier ^a   Ayats, Josefina ^a   Dominguez, Maria Angeles ^a   Gudiol, Francesc ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; BACTEREMIA; BACTERIAL COLONIZATION; EPIDEMIC; FEMALE; HOSPITAL INFECTION; HUMAN; INFECTION RISK; INTENSIVE CARE; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NOSE SMEAR; PRIORITY JOURNAL; PROSPECTIVE STUDY; STAPHYLOCOCCUS INFECTION;

EID: 17344375521     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9343(96)00014-9     Document Type: Article

References (40)

1. Boyce JM. Increasing prevalence of methicillin-resistant Staphylococcus aureus in the United States. Infect Control Hosp Epidemiol. 1990;11:639-642.
2. Panlilio AL, Culver DH, Gaynes RP, et al. Methicillin-resistant Staphylococcus aureus in U.S., 1975-1991. Infect Control Hosp Epidemiol. 1992;13:582-586.
3. Voss A, Milatovic D, Wallrauch-Schwarz C, et al. Methicillin-resistant Staphylococcus aureus in Europe. Eur J Clin Micro Infect Dis. 1994,13:50-55.
4. Faoagali JL, Thong ML, Grant D. Ten years' experience with methicillin-resistant Staphylococcus aureus in a large Australian hospital. J Hosp Infect. 1992;20:113-119.
5. Thompson RL, Cabezudo I, Wenzel RP. Epidemiology of nosocomial infections caused by methicillin-resistant Staphylococcus aureus. Ann Intern Med. 1982;97:309-317.
6. Boyce JM, White RL, Spruill EY. Impact of methicillin-resistant Staphylococcus aureus on the incidence of nosocomial staphylococcal infections. J Infect Dis. 1983;148:763.
7. Pujol M, Peña C, Pallares R, et al. Risk factors for nosocomial bacteremia due to methicillin-resistant Staphylococcus aureus. Eur J Clin Micro Infect Dis. 1994;13:96-102.
8. Weinstein HJ. The relation between the nasal staphylococcal carriage state and the incidence of post-operative complications. NEJM. 1959;260:1303-1308.
9. Henderson RJ, Williams REO. Nasal disinfection in prevention of postoperative staphylococcal infection of wounds. BMJ. 1961;2:330-333.
10. Kluytmans JAJW, Mouton JW, Ijzerman EPF, et al. Nasal carriage of Staphylococcus aureus as a major risk factor for wound infections after cardiac surgery. J Infect Dis. 1995;171:216-219.
11. Yu VL, Goetz A, Wagener M, et al. Staphylococcus aureus nasal carriage and infection in patients on hemodialysis. Efficacy of antibiotic prophylaxis. NEJM. 1986;315:91-96.
12. Chow JW, Yu VL. Staphylococcus aureus nasal carriage in hemodialysis patients: its role in infection and approaches to prophylaxis. Arch Intern Med. 1989;149:1258-1262.
13. Boelaert JR, De Baere YA, Geernaert MA, et al. The use of nasal mupirocin ointment to prevent Staphylococcus aureus bacteraemias in haemodialysis patients: an analysis of cost-effectiveness. J Hosp Infect. 1991;19(suppl B):41-46.
14. Working Party Report. Revised guidelines for the control of epidemic methicillin-resistant Staphylococcus aureus. J Hosp Infect. 1990;16:351-377.
15. Casewell MW, Hill RLR. The carrier state: methicillin-resistant Staphylococcus aureus. J Antimicrob Chemother. 1986;18,suppl A:1-12.
16. McCabe WR, Jackson GG. Gram negative bacteremia. Am J Med. 1962;110:847-855.
17. Le Gall JR, Loirat P, Alpérovich A, et al. A simplified acute physiology score for ICU patients. Crit Care Med. 1984;12:975-977.
18. Garner JS, Jarvis WR, Emori TG, et al. CDC definitions for nosocomial infections, 1988. Am J Infect Control. 1988;16:128-140.
19. NCCLS. Performance Standards for Antimicrobial Disk Susceptibility Test. 4th ed. Approved standard M2-A4.NCCLS, Villanova, Penn; 1990.
20. Dominguez MA, de Lencastre H, Liñares J, Tomasz A. Spread and main-tenance of a dominant methicillin-resistant Staphylococcus aureus (MRSA) clone during an outbreak of MRSA disease in a Spanish hospital. J Clin Microbiol. 1994;32:2081-2087.
21. Willems FTC. Epidemiology of nasal carriage of Staphylococcus aureus. In: van der Meer JWM, ed. Nasal Carriage of Staphylococcus aureus. A Round-Table Discussion. Amsterdam: Excerpta Medica; 1990:3-6.
22. Tuazon CU, Perez A, Kishaba T, Sheagren JN. Staphylococcus aureus among insulin-injecting diabetic patients: an increased carriage rate. JAMA. 1975;231:1272.
23. Weinke T, Schiller R, Fehrenbach FJ, Pohle H.D. Association between Staphylococcus aureus nasopharyngeal colonization and septicemia in patients infected with the human immunodeficiency virus. Eur J Clin Micro Infect Dis. 1992;11:985-989.
24. Regnier B, Decré D. Eradication of nasal carriage of Staphylococcus aureus by mupirocin in an intensive care unit. In: van der Meer JWM, ed. Nasal Carriage of Staphylococcus aureus. A Round-Table Discussion. Amsterdam: Exerpta Medica; 1990:7-14.
25. Brun-Buisson C, Rauss A, Legrand P, et al. Traitement du portage nasal de Staphylococcus aureus par la mupirocie nasal et prévention des infections acquises en préanimation. Etude multicentrique contrôlée. Med Mal Infect 1994;24:1229-1239.
26. Ward TT. Comarison of in vitro adherence of methicillin-sensitive and methicillin-resistant Staphylococcus aureus to human nasal epithelial cells. J Infect Dis. 1992;166:400-404.
27. Crossley K, Loesch D, Landesman B, et al. An outbreak of infections caused by Staphylococcus aureus resistant to methicillin and aminoglycosides. I. Clinical studies. J Infect Dis. 1979;139:273-287.
28. Peacock JE, Marsik FJ, Wenzel RP. Methicillin-resistant Staphylococcus aureus: introduction and spread within a hospital. Ann Intern Med. 1980;93:526-532.
29. Linnemann CC, Mason M, Moore P, et al. Methicillin-resistant Staphylococcus aureus: experience in a general hospital over four years. Am J Epidemiol. 1982;115:941-950.
30. Cohen SH, Morita MM, Bradford M. A seven-year experience with methicillin-resistant Staphylococcus aureus. Am J Med. 1991;91(suppl 3B):233S-237S.
31. Coello R, Jimenez J, Garc[ilac]a M, et al. Prospective study of infection, colonization and carriage of methicillin-resistant Staphylococcus aureus in an outbreak affecting 990 patients. Eur J Clin Micro Infect Dis. 1994;13:74-81.
32. Muder RR, Brennen C, Wagener MM, et al. Methicillin-resistant staphylococcal colonization and infection in a long-term care facility. Ann Intern Med. 1991;114:107-112.
33. Myers JP, Linnemann CC. Bacteremia due to methicillin-resistant Staphylococcus aureus. J Infect Dis. 1982;145:532-536.
34. Craven DE, Kollisch NR, Hsieh CR, et al. Vancomycin treatment of bacteremia caused by oxacillin-resistant Staphylococcus aureus: comparison with B-lactam antibiotic treatment of bacteremia caused by oxacillin-sensitive Staphylococcus aureus. J Infect Dis. 1983;147:137-143.
35. Lewis E, Saravolatz LD. Comparison of methicillin-resistant and methicillin-sensitive Staphylococcus aureus bacteremia. Am J Infect Control. 1985;13:109-114.
36. French GL, Cheng AFB, Ling JM, et al. Hong Kong strains of methicillin-resistant and methicillin-sensitive Staphylococcus aureus have similar virulence. J Hosp Infect. 1990:15;117-125.
37. Hershow RC, Khayr WF, Smth N. A comparison of clinical virulence of nosocomially acquired methicillin-resistant Staphylococcus aureus infections in a university hospital. Infect Control Hosp Epidemiol. 1992;13:587-593.
38. Coleman DC. Methicillin-resistant Staphylococcus aureus: molecular epidemiology and expression of virulence determinants. In: Cafferkey MT, ed. Methicillin-Resistant Staphylococcus aureus. Clinical Management and Laboratory Aspects. Infectious Disease and Therapy. New York: Marcel Dekker; 1992:37-56.
39. Duckworth GJ, Jordens JZ. Adherence and survival properties of an epidemic methicillin-resistant strain of Staphylococcus aureus compared with those of methicillin-sensitive strains. J Med Microbiol. 1990:32;195-200.
40. Joerdens JZ, Duckworth GJ, Williams RJ. Production cf virulence factors by epidemic methicillin-resistant Staphylococcus aureus in vitro. J Med Microbiol. 1989:30;245-252.